A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites

BACKGROUND: Ramucirumab has recently proved to be effective for advanced or recurrent gastric cancer (AGC). Ascites and peritoneal metastasis are among the most common complications of AGC. However, there are few data on the safety and efficacy of paclitaxel plus ramucirumab in patients with AGC wit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Matsumoto, Hiroshi, Kawazoe, Akihito, Shimada, Kaoru, Fukuoka, Shota, Kuboki, Yasutoshi, Bando, Hideaki, Kojima, Takashi, Ohtsu, Atsushi, Yoshino, Takayuki, Doi, Toshihiko, Shitara, Kohei
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5793350/
https://ncbi.nlm.nih.gov/pubmed/29385993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4057-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados